Contineum Therapeutics (CTNM) Change in Accrued Expenses (2023 - 2026)
Contineum Therapeutics (CTNM) posted Change in Accrued Expenses of $1.03 million for Q3 2026, up 194.3% from $351,000 a year earlier and up 34.5% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Change in Accrued Expenses (2023 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Contineum Therapeutics was $373,000, up 14.8% year-over-year; for FY2025, it was -$516,000.
- In prior years, Contineum Therapeutics' Change in Accrued Expenses was $2.3 million in FY2024 (+44.5%) and $1.59 million in FY2023.
- Quarterly Change in Accrued Expenses has run from a low of -$3.53 million in Q1 2026 to a high of $2.94 million in Q4 2024 over five years.
- According to Business Quant data, Change in Accrued Expenses for the three prior quarters was $768,000 (Q2 2026), -$3.53 million (Q1 2026) and $2.1 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.03 Mn |
| Jun 30, 2026 | 768,000.00 |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 351,000.00 |
| Jun 30, 2025 | -102,000.00 |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | -1.46 Mn |
| Mar 31, 2024 | -380,000.00 |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | -978,000.00 |
API Access
Contineum Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();